Deliverables
Engagement, communication & dissemination of recent development and progress on ATXA’s lead drug NTP42 including with key opinion leaders (KOLs) and other stakeholders of relevance to pulmonary arterial hypertension (PAH).
Searching for OpenAIRE data...
Publications
Author(s): Eamon P. Mulvaney, Helen M. Reid, Lucia Bialesova, Pedro Mendes-Ferreira, Rui Adão, Carmen Brás-Silva, B. Therese Kinsella
Published in: European Journal of Pharmacology, 889, 2020, Page(s) 173658, ISSN 0014-2999
Publisher: Elsevier BV
DOI: 10.1016/j.ejphar.2020.173658
Author(s): Eamon P. Mulvaney, Áine G. O'Sullivan, Sarah B. Eivers, Helen M. Reid, B. Therese Kinsella
Published in: Experimental and Molecular Pathology, 110, 2019, Page(s) 104277, ISSN 0014-4800
Publisher: Academic Press
DOI: 10.1016/j.yexmp.2019.104277
Author(s): Eamon P. Mulvaney, Helen M. Reid, Lucia Bialesova, Annie Bouchard, Dany Salvail, B. Therese Kinsella
Published in: BMC Pulmonary Medicine, 20/1, 2020, ISSN 1471-2466
Publisher: BioMed Central
DOI: 10.1186/s12890-020-1113-2
Author(s): T Kinsella, E Mulvaney, HM Reid
Published in: European Respiratory Journal, 2019, Page(s) PA5048
Publisher: European Respiratory Society
Author(s): T Kinsella, E Mulvaney, HM Reid
Published in: European Journal of Cardiology, 40, 2019, Page(s) P3670
Publisher: Oxford Academic